Applications of 1-Phenylpropan-1-Amine in Industrial Manufacturing

As a direct manufacturer specializing in 1-Phenylpropan-1-Amine, we focus on supply to tightly defined downstream industrial segments where this raw material plays a critical role in synthesis, process control, and end-product specification. Our technical support and supply chain solutions integrate deeply into established production systems, ensuring functional, regulatory, and quality alignment with the requirements of advanced chemical and pharmaceutical producers.

1. Active Pharmaceutical Ingredient (API) Intermediate for Sympathomimetic Agents

Pharmaceutical companies use this amine as a building block in the synthesis of specific sympathomimetic drug molecules, particularly those used in decongestants and central nervous system stimulants. The material’s structural properties facilitate high-purity conversion under controlled reaction conditions, contributing to final active compounds with defined stereochemistry and regulatory traceability.

Industry compliance standards

• Current Good Manufacturing Practice (cGMP, 21 CFR Parts 210/211)
• United States Pharmacopeia (USP) Monographs relevant to APIs containing substituted propylamines
• ICH Q7: Good Manufacturing Practice for Active Pharmaceutical Ingredients
• European Pharmacopoeia (Ph. Eur.) chapter references for relevant APIs

Typical usage ratio

• 350–480 g per mole of target API; adjusted per reaction yield and purification step yield

Downstream process integration

• Alkylation or reductive amination stages in the formation of active intermediates
• Batch hydrogenation under strict temperature and solvent control
• Recrystallization as required for purity assurance

Final product types

• Bulk pseudoephedrine and phenylpropanolamine intermediates
• Finished tablets, syrups, and capsules for decongestant or stimulant medication

2. Fine Chemical Synthesis: Production of Chiral Ligands and Catalysts

Specialty chemical operations deploy this material as a precursor for the synthesis of chiral ligands, which play a key role in enantioselective catalysis for advanced organic synthesis. In this scenario, the raw material’s amine group provides a reactive center for further functionalization, and its aromatic moiety supports selective coordination chemistry.

Industry compliance standards

• ISO 9001:2015 Quality Management for Fine Chemicals
• REACH Regulation (EC) No 1907/2006 regarding chemical registration and handling
• OECD Good Laboratory Practice (GLP) for process development
• Chemical safety assessment according to GHS/CLP standards

Typical usage ratio

• 10–35% molar equivalent per target ligand produced; adjusted based on ligand structure and reaction pathway

Downstream process integration

• Nucleophilic addition to aldehyde or ketone substrates in ligand assembly
• Condensation reactions in chiral backbone synthesis
• Solvent extraction and purification via preparative chromatography

Final product types

• Enantioselective chiral ligands for organometallic catalysis
• Homogeneous catalysts used in fine chemical and API manufacture

3. Agrochemical Intermediate for Plant Growth Regulator Synthesis

Agrochemical plants incorporate this molecule during the manufacture of certain phenylalkylamine-based plant growth regulators. Its chemical attributes permit reliable downstream functionalization, ensuring adherence to tight impurity limits and enhancing regulatory traceability within the agricultural supply chain.

Industry compliance standards

• FAO/WHO Joint Meeting on Pesticide Specifications (JMPS)
• EU Regulation (EC) No 1107/2009 regarding plant protection products
• ISO 17025:2017 Analytical Testing Laboratories
• CropLife International Stewardship principles

Typical usage ratio

• 120–220 g per kg of target regulator; precise dosage matched to molecular transformation yield

Downstream process integration

• Step-growth amination to introduce primary amine functionality before ring closure
• Sequential oxidation and reduction to achieve desired bioactive conformation
• Quality control via HPLC and GC for impurity profiling

Final product types

• Phenylalkylamine-based plant growth regulators (e.g., phenylaminoacetates)
• Finished formulations for cereal, vegetable, and horticultural crop applications

4. Aroma Ingredient Synthesis for Flavors and Fragrances

Within the flavors and fragrance industry, chemical synthesis units employ this compound during the design of specific aroma intermediates. Its amine core allows for tailored derivatization to yield benzylamine-based aroma chemicals, with production processes subjected to strict traceability and food safety verification.

Industry compliance standards

• FEMA (Flavor and Extract Manufacturers Association) GRAS list procedures
• European Union Food Flavour Regulation (EC) No. 1334/2008
• ISO 22000 Food Safety Management Systems
• Chemical quality control per IFRA (International Fragrance Association) standards

Typical usage ratio

• 20–60 g per kg of target aroma intermediate; ratio varies according to derivative synthesis step

Downstream process integration

• Initial functionalization to produce benzyl or substituted phenylamines
• Esterification or acylation to generate key aroma compounds
• Fractional distillation and aroma profile assessment by GC-olfactometry

Final product types

• Synthetic intermediates for fruity, floral, or spicy fragrance notes
• Flavor precursors for food and beverage industries
• Complex fragrance compounds for perfumery bases

5. Pharmaceutical Impurity Reference Substance Manufacturing

Reference substance suppliers and pharmaceutical quality control facilities synthesize and qualify impurity standards based on this chemical’s unique structure. The compound facilitates the reproducible manufacture of traceable reference materials, supporting analytical method validation and product release testing in drug manufacturing environments.

Industry compliance standards

• USP General Chapter <11> Reference Standards
• ISO 17034:2016 for Reference Material Producers
• ICH Q3A/B guidelines on impurities in drug substances and products
• GLP-compliant analytical validation protocols

Typical usage ratio

• Compound converted to reference substance at 0.1–2% wt/wt depending on required impurity level and lot size

Downstream process integration

• Analytical-scale synthesis or isolation during API batch manufacture
• Subsequent purification using preparative HPLC or recrystallization
• Comprehensive characterization (NMR, MS, IR)

Final product types

• Drug impurity reference standards for pharmaceutical QC
• Certified impurity markers for regulatory dossier submissions
• Analytical calibration kits for HPLC or GC systems